{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:34:38Z","timestamp":1778175278244,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the \u201cRegional Health Research Program 2009\u201d from the Regione Toscana, Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The endothelial nitric oxide synthase (eNOS) gene deficiency is known to cause impaired coronary vasodilating capability in animal models. In the general clinical population, the eNOS gene polymorphisms, able to affect eNOS activity,  were associated with cardiometabolic risk features and prevalence of coronary artery disease (CAD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To investigate the association of <jats:italic>eNOS<\/jats:italic> Glu298Asp gene polymorphism, cardiometabolic profile, obstructive CAD and inducible myocardial ischemia in patients with suspected stable CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 506 patients (314 males; mean age 62\u2009\u00b1\u20099 years) referred for suspected CAD was enrolled. Among these, 325 patients underwent stress ECG or cardiac imaging to assess the presence of inducible\u00a0myocardial\u00a0ischemia and 436 patients underwent non-invasive computerized tomography or invasive coronary angiography to assess the presence of obstructive CAD. Clinical characteristics and blood samples were collected for each patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the whole population, 49.6% of patients were homozygous for the Glu298 genotype (Glu\/Glu), 40.9% heterozygotes (Glu\/Asp) and 9.5% homozygous for the 298Asp genotype (Asp\/Asp). Obstructive CAD was documented in 178\/436 (40.8%) patients undergoing coronary angiography while myocardial ischemia in 160\/325 (49.2%) patients undergoing stress testing. Patients with <jats:italic>eNOS<\/jats:italic> Asp genotype (Glu\/Asp\u2009+\u2009Asp\/Asp) had no significant differences in clinical risk factors and in circulating markers. Independent predictors of obstructive CAD were age, gender, obesity, and low HDL-C. Independent predictors of myocardial ischemia were gender, obesity, low HDL-C and Asp genotype. In the subpopulation in which both stress tests and coronary angiography were performed, the Asp genotype remained associated with increased myocardial ischemia risk after adjustment for obstructive CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this population, low-HDL cholesterol was the only cardiometabolic risk determinant of obstructive CAD. The <jats:italic>eNOS<\/jats:italic> Glu298Asp gene polymorphism was significantly associated with inducible myocardial ischemia independently of other risk factors and presence of obstructive CAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03846-7","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:16:22Z","timestamp":1711095382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low HDL cholesterol and the eNOS Glu298Asp polymorphism are associated with inducible myocardial ischemia in patients with suspected stable coronary artery disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Cecilia","family":"Vecoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Modena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Poddighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafina","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ghiadoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Clerico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Prontera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Vittorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Botto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Neglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"3846_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.113.004046","volume":"129","author":"AE Moran","year":"2014","unstructured":"Moran AE, Forouzanfar MH, Roth G, Mensah GA, Ezzati M, Flaxman A. Christopher J L Murray, Mohsen Naghavi The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation. 2014;129:1493\u2013501.","journal-title":"Circulation"},{"key":"3846_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD; 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD; 2015 Mortality and Causes of Death Collaborators. Global, regional and national life expectancy, all-cause mortality and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459\u2013544.","journal-title":"Lancet"},{"key":"3846_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol. 2022;80:2361\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"3846_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","volume":"86","author":"F Crea","year":"2022","unstructured":"Crea F, Montone RA, Rinaldi R. Pathophysiology of Coronary Microvascular Dysfunction. Circ J. 2022;86:1319\u201328.","journal-title":"Circ J"},{"key":"3846_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1177\/0003319720987752","volume":"72","author":"P Poredos","year":"2021","unstructured":"Poredos P, Poredos AV, Gregoric I. Endothelial Dysfunction and Its Clinical Implications. Angiology. 2021;72:604\u201315.","journal-title":"Angiology"},{"key":"3846_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/333664a0","volume":"333","author":"RM Palmer","year":"1988","unstructured":"Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664\u20136.","journal-title":"Nature"},{"key":"3846_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.CIR.104.3.342","volume":"104","author":"H Duplain","year":"2001","unstructured":"Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342\u20135.","journal-title":"Circulation"},{"key":"3846_CR8","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.2337\/diabetes.53.8.2067","volume":"53","author":"S Cook","year":"2004","unstructured":"Cook S, Hugli O, Egli M, Menard B, Thalmann S, Sartori C, Perrin C, Nicod P, Thorens B, Vollenweider P, et al. Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes. 2004;53:2067\u201372.","journal-title":"Diabetes"},{"key":"3846_CR9","doi-asserted-by":"publisher","first-page":"e104156","DOI":"10.1371\/journal.pone.0104156","volume":"9","author":"C Vecoli","year":"2014","unstructured":"Vecoli C, Novelli M, Pippa A, Giacopelli D, Beffy P, Masiello P, L\u2019Abbate A, Neglia D. Partial deletion of eNOS gene causes hyperinsulinemic state, unbalance of cardiac insulin signaling pathways and coronary dysfunction independently of high fat diet. PLoS ONE. 2014;9:e104156\u201366.","journal-title":"PLoS ONE"},{"issue":"3","key":"3846_CR10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.ygeno.2020.01.019","volume":"112","author":"J Yu","year":"2020","unstructured":"Yu J, Wu X, Ni J, Zhang J. Relationship between common eNOS gene polymorphisms and predisposition to coronary artery disease: Evidence from a meta-analysis of 155 published association studies. Genomics. 2020;112(3):2452\u20138.","journal-title":"Genomics"},{"key":"3846_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/diabetes.52.5.1270","volume":"52","author":"LD Monti","year":"2003","unstructured":"Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G, Piatti P. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52:1270\u20135.","journal-title":"Diabetes"},{"key":"3846_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1373\/clinchem.2006.075176","volume":"53","author":"JL Gonzalez-Sanchez","year":"2007","unstructured":"Gonzalez-Sanchez JL, Martinez-Larrad MT, Saez ME, Zabena C, Martinez-Calatrava MJ, Serrano-Rios M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem. 2007;53:91\u20137.","journal-title":"Clin Chem"},{"key":"3846_CR13","first-page":"116","volume":"8","author":"P Severino","year":"2021","unstructured":"Severino P, D\u2019Amato A, Prosperi S, Magnocavallo M, Mariani MV, Netti L, Birtolo LI, De Orchi P, Chimenti C, Maestrini V, et al. Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation. J Cardiovasc Dev Dis. 2021;8:116.","journal-title":"J Cardiovasc Dev Dis"},{"key":"3846_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-07-0632","volume":"158","author":"A Imamura","year":"2008","unstructured":"Imamura A, Takahashi R, Murakami R, Kataoka H, Cheng XW, Numaguchi Y, Murohara T, Okumura K. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. Eur J Endocrinol. 2008;158:189\u201395.","journal-title":"Eur J Endocrinol"},{"key":"3846_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2350-13-92","volume":"13","author":"C Vecoli","year":"2012","unstructured":"Vecoli C, Andreassi MG, Liga R, Colombo MG, Coceani M, Carpeggiani C, L\u2019Abbate A, Neglia D. T(-786)\u2192C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy. BMC Med Genet. 2012;13:92.","journal-title":"BMC Med Genet"},{"key":"3846_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-020-01166-6","volume":"19","author":"MJ Guembe","year":"2020","unstructured":"Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C, for the RIVANA Study Investigators. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19:195.","journal-title":"Cardiovasc Diabetol"},{"key":"3846_CR17","first-page":"20714","volume":"11","author":"C Caselli","year":"2021","unstructured":"Caselli C, De Caterina R, Smit JM, Campolo J, El Mahdiui M, Ragusa R, Clemente A, Sampietro T, Clerico A, Liga R, et al. EVINCI and SMARTool. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina Sci Rep. 2021;11:20714.","journal-title":"Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina Sci Rep"},{"key":"3846_CR18","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"3846_CR19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/ijerph18041773","volume":"18","author":"AF Alshammary","year":"2021","unstructured":"Alshammary AF, Alharbi KK, Alshehri NJ, Vennu V, Ali KI. Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies. Int J Environ Res Public Health. 2021;18:1773.","journal-title":"Int J Environ Res Public Health"},{"key":"3846_CR20","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, et al. ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"issue":"41","key":"3846_CR21","first-page":"407","volume":"2020","author":"J Knuuti","year":"2019","unstructured":"Knuuti J, WijnsW SA, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al. ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2019;2020(41):407\u201377.","journal-title":"Eur Heart J"},{"key":"3846_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jdi.13118","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Chen G, Qin H, Cai Z, Huang J, Chen H, Wu W, Chen Z, Wu S, Chen Y. Higher triglyceride to high-density lipoprotein cholesterol ratio increases cardiovascular risk: 10-year prospective study in a cohort of Chinese adults. J Diabetes Investig. 2020;11:475\u201381.","journal-title":"J Diabetes Investig"},{"key":"3846_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cca.2013.12.001","volume":"429","author":"\u00d3 P\u00e9rez-M\u00e9ndez","year":"2014","unstructured":"P\u00e9rez-M\u00e9ndez \u00d3, Pacheco HG, Mart\u00ednez-S\u00e1nchez C, Franco M. HDL-cholesterol in coronary artery disease risk: Function or structure? Clin Chim Acta. 2014;429:111\u201322.","journal-title":"Clin Chim Acta"},{"key":"3846_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.11.013","volume":"339","author":"N Di Giorgi","year":"2021","unstructured":"Di Giorgi N, Michelucci E, Smit JM, Scholte AJHA, El Mahdiui M, Knuuti J, Buechel RR, Teresinska A, Pizzi MN, Roque A, et al. A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome. Atherosclerosis. 2021;339:1\u201311.","journal-title":"Atherosclerosis"},{"key":"3846_CR25","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","volume":"26","author":"A Pirillo","year":"2019","unstructured":"Pirillo A, Catapano AL, Norata GD. Biological Consequences of Dysfunctional HDL. Curr Med Chem. 2019;26:1644\u201364.","journal-title":"Curr Med Chem"},{"key":"3846_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","volume":"44","author":"A von Eckardstein","year":"2023","unstructured":"von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL. High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2023;44:1394\u2013407.","journal-title":"Eur Heart J"},{"key":"3846_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Y Alexander","year":"2021","unstructured":"Alexander Y, Osto E, Schmidt-Trucks\u00e4ss A, Shechter M, Trifunovic D, Duncker DJ, Aboyans V, B\u00e4ck M, Badimon L, Cosentino F, et al. Endothelial function in cardiovascular medicine: A consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc Res. 2021;117:29\u201342.","journal-title":"Cardiovasc Res"},{"key":"3846_CR28","doi-asserted-by":"crossref","unstructured":"Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AHEM, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EuroIntervention. 2021;16:1049\u201369.","DOI":"10.4244\/EIJY20M07_01"},{"key":"3846_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","volume":"116","author":"T Padro","year":"2020","unstructured":"Padro T, Manfrini O, Bugiardini R, Canty J, Cenko E, De Luca G, Duncker DJ, Eringa EC, Koller A, Tousoulis D, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on \u2018coronary microvascular dysfunction in cardiovascular disease. Cardiovasc Res. 2020;116:741\u201355.","journal-title":"Cardiovasc Res"},{"key":"3846_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830\u201340.","journal-title":"N Engl J Med"},{"key":"3846_CR31","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1073\/pnas.97.6.2832","volume":"6","author":"M Tesauro","year":"2000","unstructured":"Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;6:2832\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3846_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/hmg\/11.3.229","volume":"11","author":"A Persu","year":"2002","unstructured":"Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, et al. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet. 2002;11:229\u201341.","journal-title":"Hum Mol Genet"},{"key":"3846_CR33","doi-asserted-by":"publisher","first-page":"26674","DOI":"10.1074\/jbc.M103647200","volume":"276","author":"TA Fairchild","year":"2001","unstructured":"Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu (298)\/asp variant of human endothelial nitric-oxide synthase. J Biol Chem. 2001;276:26674\u20139.","journal-title":"J Biol Chem"},{"key":"3846_CR34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/00008571-200412000-00006","volume":"14","author":"DM McDonald","year":"2004","unstructured":"McDonald DM, Alp NJ, Channon KM. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics. 2004;14:831\u20139.","journal-title":"Pharmacogenetics"},{"key":"3846_CR35","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1096\/fj.06-7088com","volume":"21","author":"MS Joshi","year":"2007","unstructured":"Joshi MS, Mineo C, Shaul PW, Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J. 2007;21:2655\u201363.","journal-title":"FASEB J"},{"issue":"431\u20136","key":"3846_CR36","first-page":"37","volume":"34","author":"AM Zigra","year":"2013","unstructured":"Zigra AM, Rallidis LS, Anastasiou G, Merkouri E, Gialeraki A. eNOS gene variants and the risk of premature myocardial infarction. Dis Markers. 2013;34(431\u20136):37.","journal-title":"Dis Markers"},{"key":"3846_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cca.2010.01.013","volume":"411","author":"I Isordia-Salas","year":"2010","unstructured":"Isordia-Salas I, Lea\u00f1os-Miranda A, Borrayo-S\u00e1nchez G. The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta. 2010;411:553\u20137.","journal-title":"Clin Chim Acta"},{"key":"3846_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/01.mca.0000073080.69657.71","volume":"14","author":"K Chang","year":"2003","unstructured":"Chang K, Baek SH, Seung KB, Kim PJ, Ihm SH, Chae JS, Kim JH, Hong SJ, Choi KB. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis. 2003;14:293\u20139.","journal-title":"Coron Artery Dis"},{"key":"3846_CR39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0735-1097(02)03011-5","volume":"41","author":"GP Rossi","year":"2003","unstructured":"Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, Versari D, Sudano I, Pessina AC, Salvetti A. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol. 2003;41:938\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"3846_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087196","volume":"9","author":"JQ Luo","year":"2014","unstructured":"Luo JQ, Wen JG, Zhou HH, Chen XP, Zhang W. Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: A meta-analysis of 34 studies involving 21,068 subjects. PLoS ONE. 2014;9: e87196.","journal-title":"PLoS ONE"},{"key":"3846_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier P, Giles T, Bray G, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation. 2006;113:898\u2013918.","journal-title":"Circulation"},{"key":"3846_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/met.2017.0152","volume":"16","author":"M Azab","year":"2018","unstructured":"Azab M, Al-Shudifat AE, Johannessen A, Al-Shdaifat A, Agraib LM, Tayyem RF. Are risk factors for coronary artery disease different in persons with and without obesity? Metab Syndr Relat Disord. 2018;16:440\u20135.","journal-title":"Metab Syndr Relat Disord"},{"key":"3846_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11883-016-0575-4","volume":"18","author":"T Mandviwala","year":"2016","unstructured":"Mandviwala T, Khalid U, Deswal A. Obesity and cardiovascular disease:a risk factor or a risk marker? Curr Atheroscl Rep. 2016;18:21.","journal-title":"Curr Atheroscl Rep"},{"key":"3846_CR44","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/ijo.2016.125","volume":"40","author":"A De Schutter","year":"2016","unstructured":"De Schutter A, Kachur S, Lavie CJ, Boddepalli RS, Patel DA, Milani RV. The impact of inflammation on the obesity paradox in coronary heart disease. Int J Obes. 2016;40:1730\u20135.","journal-title":"Int J Obes"},{"key":"3846_CR45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/cvr\/cvx093","volume":"113","author":"O Sorop","year":"2017","unstructured":"Sorop O, Olver TD, van de Wouw J, Heinonen I, van Duin RW, Duncker DJ, Merkus D. The microcirculation: a key player in obesity-associated cardiovascular disease. Cardiovasc Res. 2017;113:1035\u201345.","journal-title":"Cardiovasc Res"},{"key":"3846_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41366-020-00655-8","volume":"45","author":"L Cortigiani","year":"2021","unstructured":"Cortigiani L, Haberka M, Ciampi Q, Bovenzi F, Villari B, Picano E. The obesity paradox in the stress echo lab: fat is better for hearts with ischemia or coronary microvascular dysfunction. Int J Obes (Lond). 2021;45:308\u201315.","journal-title":"Int J Obes (Lond)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03846-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:19:58Z","timestamp":1711095598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03846-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Coordinating Center Ethical Committee and all local Ethical Committees. All patients included in the study signed a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}